253 related articles for article (PubMed ID: 7679150)
1. Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel.
Chi L; Black SC; Kuo PI; Fagbemi SO; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Feb; 21(2):179-90. PubMed ID: 7679150
[TBL] [Abstract][Full Text] [Related]
2. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
Fagbemi SO; Chi L; Lucchesi BR
J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
[TBL] [Abstract][Full Text] [Related]
3. Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels.
Friedrichs GS; Chi L; Black SC; Manley PJ; Oh JY; Lucchesi BR
J Pharmacol Exp Ther; 1993 Sep; 266(3):1348-54. PubMed ID: 8371141
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart.
Friedrichs GS; Chi L; Black SC; Manley PJ; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Jan; 23(1):120-6. PubMed ID: 7511723
[TBL] [Abstract][Full Text] [Related]
5. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
Fischbach PS; White A; Barrett TD; Lucchesi BR
J Pharmacol Exp Ther; 2004 May; 309(2):554-9. PubMed ID: 14747611
[TBL] [Abstract][Full Text] [Related]
6. Antifibrillatory effects of clofilium in the rabbit isolated heart.
Friedrichs GS; Chi L; Green AL; Lucchesi BR
Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
[TBL] [Abstract][Full Text] [Related]
7. Endogenous adenosine does not activate ATP-sensitive potassium channels in the hypoxic guinea pig ventricle in vivo.
Xu J; Wang L; Hurt CM; Pelleg A
Circulation; 1994 Mar; 89(3):1209-16. PubMed ID: 8124809
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart.
Gralinski MR; Chi L; Park JL; Friedrichs GS; Tanhehco EJ; McCormack JG; Lucchesi BR
J Cardiovasc Pharmacol Ther; 1996 Apr; 1(2):141-148. PubMed ID: 10684411
[TBL] [Abstract][Full Text] [Related]
9. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
[TBL] [Abstract][Full Text] [Related]
10. Effects of K(ATP) channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts.
Jilkina O; Kuzio B; Grover GJ; Kupriyanov VV
J Mol Cell Cardiol; 2002 Apr; 34(4):427-40. PubMed ID: 11991732
[TBL] [Abstract][Full Text] [Related]
11. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
Wolleben CD; Sanguinetti MC; Siegl PK
J Mol Cell Cardiol; 1989 Aug; 21(8):783-8. PubMed ID: 2506353
[TBL] [Abstract][Full Text] [Related]
12. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide.
Black SC; Fagbemi SO; Chi L; Friedrichs GS; Lucchesi BR
J Mol Cell Cardiol; 1993 Dec; 25(12):1427-38. PubMed ID: 8158662
[TBL] [Abstract][Full Text] [Related]
14. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
[TBL] [Abstract][Full Text] [Related]
15. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
Nakaya H; Takeda Y; Tohse N; Kanno M
Br J Pharmacol; 1991 May; 103(1):1019-26. PubMed ID: 1908730
[TBL] [Abstract][Full Text] [Related]
16. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.
Cole WC; McPherson CD; Sontag D
Circ Res; 1991 Sep; 69(3):571-81. PubMed ID: 1908354
[TBL] [Abstract][Full Text] [Related]
17. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
MacKenzie I; Saville VL; Waterfall JF
Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
[TBL] [Abstract][Full Text] [Related]
18. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
19. SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel.
Fischbach PS; Barrett TD; Reed NJ; Lucchesi BR
J Cardiovasc Pharmacol; 2003 May; 41(5):744-50. PubMed ID: 12717105
[TBL] [Abstract][Full Text] [Related]
20. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
